DeepMed Research

Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Biological: cetuximab

First Posted Date: 2005-02-08

Last Posted Date: 2023-06-28

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 72

Registration Number: NCT00103207

Locations: 🇺🇸
St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸
Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton, Florida, United States
🇺🇸
Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States

and more 154 locations

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Phase 2

Withdrawn

Conditions: Adult Acute Erythroid Leukemia
Adult Acute Monoblastic and Acute Monocytic Leukemia
Adult Acute Myeloid Leukemia

First Posted Date: 2005-01-10

Last Posted Date: 2017-10-19

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00101140

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Phase 2

Completed

Conditions: Mesothelioma

Interventions: Drug: pemetrexed disodium
Drug: gemcitabine hydrochloride
Drug: carboplatin

First Posted Date: 2005-01-10

Last Posted Date: 2023-07-03

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 32

Registration Number: NCT00101283

Locations: 🇺🇸
St. Rita's Medical Center, Lima, Ohio, United States
🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Mason District Hospital, Havana, Illinois, United States

and more 112 locations

Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Biological: bevacizumab
Drug: irinotecan hydrochloride
Drug: fluorouracil
Drug: leucovorin calcium
Drug: Oxaliplatin

First Posted Date: 2004-12-09

Last Posted Date: 2023-07-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 247

Registration Number: NCT00098787

Locations: 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸
St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸
Humphrey Cancer Center at North Memorial Outpatient Center, Robbinsdale, Minnesota, United States

and more 107 locations

Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Biological: cetuximab C225
Drug: cisplatin
Radiation: radiation therapy

First Posted Date: 2004-11-09

Last Posted Date: 2023-06-29

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 69

Registration Number: NCT00096174

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Not Applicable

Withdrawn

Conditions: Melanoma (Skin)
Ovarian Cancer
Sarcoma
Unspecified Adult Solid Tumor, Protocol Specific
Cachexia
Lymphoma
Pain

First Posted Date: 2004-10-08

Last Posted Date: 2015-10-08

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00093678

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-09-13

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003353

Locations: 🇺🇸
CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
University of Rochester Cancer Center, Rochester, New York, United States

and more 14 locations

Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2004-09-08

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00090974

Locations: 🇺🇸
North Colorado Medical Center, Greeley, Colorado, United States
🇺🇸
McKee Medical Center, Loveland, Colorado, United States
🇺🇸
Hematology Oncology Associates of the Quad Cities, Bettendorf, Iowa, United States

and more 221 locations

Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer

Phase 2

Completed

Conditions: Gastric Cancer

First Posted Date: 2004-09-06

Last Posted Date: 2013-06-21

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003172

Locations: 🇺🇸
CCOP - Marshfield Medical Research and Education Foundation, Marshfield, Wisconsin, United States
🇺🇸
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - St. Francis Hospital/Natalie Warren Bryant Cancer Center, Tulsa, Oklahoma, United States

and more 22 locations

Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

Phase 3

Completed

Conditions: Metastatic Cancer

First Posted Date: 2004-09-02

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 480

Registration Number: NCT00002872

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy